AstraZeneca Working With Mass General on Tech for Heart Failure, Asthma

AstraZeneca Working With Mass General on Tech for Heart Failure, Asthma

Posted May 26, 2021 from
Community%20of%20Practice/Join/green?scale=1.5


The biotechnology company AstraZeneca announced on Tuesday that it would be collaborating with Massachusetts General Hospital to create and clinically validate patient-centric digital health solutions.

According to the company, the collaboration will use AstraZeneca's new AMAZE disease management platform to study heart failure and asthma management.

"We are incredibly proud to be working closely with Massachusetts General Hospital to utilize this digital platform to close gaps in patient care, ultimately leading to better outcomes," said Ruud Dobber, president of the BioPharmaceuticals Business Unit at AstraZeneca.

"Digital medicine helps individuals manage their chronic conditions from home while staying connected to a dedicated care team that monitors their digital device readings while driving personalized results through lifestyle coaching and medication management," said Dr. David Houghton, medical director for telemedicine and digital medicine at Ochsner.

Continue reading at

Did you find this useful? Like

See Topics


Next Article

  • AstraZeneca Working With Mass General on Tech for Heart Failure, Asthma

    How Collaboration Accelerates Innovation During the Pandemic

    The healthcare industry is experiencing an era of accelerated innovation driven by the novel coronavirus pandemic. For some, the symbiotic relationship between health systems and the vendors that …

    Posted May 26, 2021